Heinz Lubenau
No más puestos en curso
Perfil
Heinz Lubenau was the founder and had founded Vaximm AG in 2008, where he held the title of Chief Executive Officer until 2022.
He has worked as a Principal at BioGeneriX AG and Servier Laboratories Ltd.
He holds a doctorate degree from The Johannes Gutenberg University of Mainz.
Antiguos cargos conocidos de Heinz Lubenau.
| Empresas | Cargo | Fin |
|---|---|---|
Vaximm AG
 Vaximm AG Miscellaneous Commercial ServicesCommercial Services Vaximm AG provides active immunotherapies for patients suffering from cancer. It develops and provides vaccines for patients suffering from cancer. The firmalso provides research, development, manufacture, marketing and sale of pharmaceutical products. The company was founded in September 2008 and is headquartered in Basel, Switzerland. | Director Ejecutivo | 01/11/2022 |
Servier Laboratories Ltd.
 Servier Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Servier Laboratories Ltd. develops and manufactures pharmaceuticals. Its product portfolio includes Lonsurf, Oncaspar, Pixuvri, Valdoxan, and Natrilix. The company was founded in 1964 and is headquartered in Stoke Poges, the United Kingdom. | Corporate Officer/Principal | - |
BioGeneriX AG
 BioGeneriX AG Pharmaceuticals: MajorHealth Technology BioGeneriX AG develops bioengineered drugs used in the treatment of anemia, cancer, renal disease, multiple sclerosis and neutropenia. The company was founded in June 2000 and is headquartered in Mannheim, Germany. | Corporate Officer/Principal | - |
Formación de Heinz Lubenau.
| The Johannes Gutenberg University of Mainz | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
BioGeneriX AG
BioGeneriX AG Pharmaceuticals: MajorHealth Technology BioGeneriX AG develops bioengineered drugs used in the treatment of anemia, cancer, renal disease, multiple sclerosis and neutropenia. The company was founded in June 2000 and is headquartered in Mannheim, Germany. | Health Technology |
Servier Laboratories Ltd.
Servier Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Servier Laboratories Ltd. develops and manufactures pharmaceuticals. Its product portfolio includes Lonsurf, Oncaspar, Pixuvri, Valdoxan, and Natrilix. The company was founded in 1964 and is headquartered in Stoke Poges, the United Kingdom. | Health Technology |
Vaximm AG
Vaximm AG Miscellaneous Commercial ServicesCommercial Services Vaximm AG provides active immunotherapies for patients suffering from cancer. It develops and provides vaccines for patients suffering from cancer. The firmalso provides research, development, manufacture, marketing and sale of pharmaceutical products. The company was founded in September 2008 and is headquartered in Basel, Switzerland. | Commercial Services |
- Bolsa de valores
- Insiders
- Heinz Lubenau
